The encyclopedia · Advertising & PR · Marketing decision · 2024
Dong-E E-Jiao fined ¥110,000 for telling children to eat e-jiao on a livestream
In January 2024 Beijing Chaoyang fined the Dong-E E-Jiao e-commerce arm ¥110,000 for livestream claims aimed at children and a fake 'back to ¥345' price.
Dong-E E-Jiao (东阿阿胶) — 东阿阿胶电子商务(北京)有限公司 · 2024-01
What happened
Dong-E E-Jiao, the state-backed maker of the prized donkey-hide gelatin tonic, pushed its products through Douyin livestreams at the height of its health-gift marketing. In those broadcasts its e-commerce arm told viewers that its e-jiao could be eaten by 'men and women, children over six, children who are growing, who are short or thin'.
The claim cut straight across the product's own label: the 阿胶片 health food was marked as unsuitable for children and adolescents, and the company could not produce any scientific basis for a food version being right for children over six. In the same broadcasts the host said e-jiao 'boosts our immunity', but the ad was delivered as voice plus video while the approved health-food ad category was text-only, and it had never been reviewed as required.
A third violation was a price fiction. On 8 May 2023 the host pitched the 阿胶糕 by warning that 'after Mother's Day, it will go back to ¥345', yet for more than a month afterwards no unit of the product ever sold at ¥345. The regulator read it as using a false or misleading price to lure people into buying.
On 15 January 2024 the Beijing Chaoyang District Market Supervision Administration fined the company ¥110,000, ordered it to correct the conduct and eliminate the impact. The penalty landed against a backdrop the same article highlights: the brand's selling expenses hit ¥1.319bn in the first three quarters of 2023, 38.48% of revenue, while its R&D spend fell for four straight years.
Why it happened
- A health-gift brand aimed a medicinal-tonic story at children on a livestream, ignoring that its own health-food label already excluded children
- The host added an unapproved 'boosts immunity' claim and a fake end-of-promotion price, stacking two more lies on top of the misplaced audience
- A marketing machine spending 38% of revenue on selling chose livestream urgency — 'it goes back to ¥345 after Mother's Day' — over anything the product could actually stand up to
The lesson
A health product's own label is a constraint marketing must read before the livestream does. Aiming a tonic at children and inventing a comeback price turns one promotion into three violations.
Aftermath
The Beijing Chaoyang regulator fined the company ¥110,000 and ordered it to correct the conduct and eliminate the impact. The case was publicised alongside the observation that the brand's selling expenses had reached 38.48% of revenue while its R&D spending fell for four consecutive years.
Sources
spotted an error? The club wants to know.
More like this
A livestream sold ordinary food as a cure for joint pain and stomach bacteria
An ordinary shoulder patch was advertised as a cure for a herniated disc
A Linyi livestream shop ran medical-device and disease-cure ads nobody had checked
Somewhere, someone solved the problem this company failed at. 2nd Opinion →

Comments · 0
Sign in to join the comments.